UCalgary study shows why drug used to treat critically ill COVID-19 patients may only benefit males

 

https://www.eurekalert.org/news-releases/935114

 

 News Release 16-Nov-2021
Research into the way our immune systems respond to COVID-19 reveals the sex of a patient may affect how well drugs work
Peer-Reviewed Publication
University of Calgary

 

A new study from the University of Calgary shows how dexamethasone, the main treatment for severe COVID-19 lung infections, alters how immune cells work, which may help male patients, but has little to no benefit for females.

-----